Abstract
This study was undertaken to evaluate the effects on blood pressure of hydrochlorothiazide (HCTZ) 12.5 mg added to valsartan 160 mg or to olmesartan 20 mg in hypertensive patients. After a 2-wk placebo period, 130 patients, aged 35 to 75 y, with diastolic blood pressure (DBP) ≥99 and
Original language | English |
---|---|
Pages (from-to) | 680-695 |
Number of pages | 16 |
Journal | Advances in Therapy |
Volume | 23 |
Issue number | 5 |
DOIs | |
Publication status | Published - Sep 2006 |
Keywords
- Hydrochlorothiazide
- Hypertension
- Olmesartan
- Valsartan
ASJC Scopus subject areas
- Medicine(all)